Fate Therapeutics(FATE) - 2019 Q4 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2019 Earnings Conference Call March 2, 2020 5:00 PM ET Company Participants Scott Wolchko - President and Chief Executive Officer Daniel Shoemaker - Chief Scientific Officer Wayne Chu - Senior Vice President of Clinical Development Conference Call Participants Mara Goldstein - Mizuho Securities USA LLC Alethia Young - Cantor Fitzgerald & Co. James Birchenough - Wells Fargo Securities, LLC Edward Tenthoff - Piper Sandler & Co. Benjamin Burnett - Stifel, Nicolaus & Com ...